Emergent Major Adverse Cardiovascular and Thromboembolic Events were Infrequent During Clinical Trials of Pegloticase,” published in the January 2025 issue of Rheumatology by Troum et al. Maintaining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback